Donna Estes Antebi – Trademark Portfolio

Entity Type: 01

Donna Estes Antebi holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 32 (Light Beverages) — 6 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 5 Nice Classification classes. The owner is based in Los Angeles, CA.

10550 Fontenelle Way

Los Angeles, CA 90077

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Donna Estes Antebi's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

32
Light Beverages (6 filings)

Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

33
Wine & Spirits (3 filings)

Alcoholic beverages (except beers)

29
Meats & Processed Foods (1 filing)

Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits

30
Staple Foods (1 filing)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademarks does Donna Estes Antebi have?

Donna Estes Antebi has 10 U.S. trademarks filed with the USPTO.

What trademark classes does Donna Estes Antebi file in?

Donna Estes Antebi files trademarks across 5 Nice Classification classes. The most active classes are Class 32 (Light Beverages), Class 5 (Pharmaceuticals), Class 33 (Wine & Spirits), Class 29 (Meats & Processed Foods), Class 30 (Staple Foods). Class 32 covers beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages.

What is Donna Estes Antebi's trademark registration success rate?

Donna Estes Antebi has a 0% trademark registration rate, with 0 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.